Inhibition of Cell Proliferation by Quindoline Derivative (SYUIQ-05) through its Preferential Interaction with c-myc Promoter G-Quadruplex-Reference-Cited by-同舟云学术

Inhibition of Cell Proliferation by Quindoline Derivative (SYUIQ-05) through its Preferential Interaction with c-myc Promoter G-Quadruplex

Published:2011-07-29 Issue:16 Volume:54 Page:5671-5679
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ou Tian-Miao¹,Lin Jing¹,Lu Yu-Jing²,Hou Jin-Qiang¹,Tan Jia-Heng¹,Chen Shu-Han¹,Li Zeng¹,Li Yan-Ping¹,Li Ding¹,Gu Lian-Quan¹,Huang Zhi-Shu¹

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou University City, Waihuan East Road 132, Guangzhou 510006, People’s Republic of China

2. Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm200062u

Reference50 articles.

1. G-Quadruplexes: Targets in Anticancer Drug Design

2. Targeting telomeres and telomerase

3. Quadruplex DNA crystal structures and drug design

4. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of novel quindoline derivatives with fork-shaped side chains as RNA G-quadruplex stabilizers for repressing oncogene NRAS translation;European Journal of Medicinal Chemistry;2024-05

2. Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry;Bioorganic Chemistry;2024-03

3. G-quadruplex ligands in cancer therapy: Progress, challenges, and clinical perspectives;Life Sciences;2024-03

4. Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy—a critical review;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-29

5. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers;Cells;2023-06-29